Mantra Bio Announces $25 Million Series A Financing to Develop Next Generation Targeted Therapeutics Based on Platform for Engineering Targeted Exosome Vehicles

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/30YVffD
via IFTTT